Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone, Louis Potters, Brian J Davis, et al.International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapyChristopher A Peters, Richard G Stock, Jamie A Cesaretti, et al.Brachytherapy|February 15, 2012
A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 updateMark K Buyyounouski, Brian J Davis, Bradley R Prestidge, et al.Radiation Research|June 28, 2008
Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancerRyan J Burri, Richard G Stock, Jamie A Cesaretti, et al.Cancer|June 19, 2009
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary responseJohnny Kao, Stuart Packer, Ha Linh Vu, et al.International Journal of Radiation Oncology, Biology, Physics|July 4, 2008
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone, Louis Potters, Brian J Davis, et al.International Journal of Radiation Oncology, Biology, Physics|December 13, 2005
ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapyChristian N Andreassen, Jens Overgaard, Jan Alsner, et al.International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variableLouis Potters, Mack Roach, Brian J Davis, et al.Cancer Treatment and Research Communications|October 13, 2020
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockadeKunal K Sindhu, Amanda Leiter, Erin Moshier, et al.BJU International|December 10, 2024
Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancerKennedy E Okhawere, Shirin Razdan, Alp Tuna Beksac, et al.Pageof 14